https://www.thebodypro.com/category/hiv-treatment-strategies/tag/conference-coverage
HIV Treatment Strategies

Conference Coverage

The Latest

Full panel for HIV Treatment Research: New Drugs and More Efficient Regimens press conference

What's New in HIV Treatment: A Report on Updates from IAS 2019

Researchers reported hopeful news on regimens with lower treatment burdens and newly developed antiretrovirals.

Steven Deeks, M.D.

The State of Cure Research for HIV and Hepatitis B: Similarities and Differences

Steven Deeks, M.D., talks about the medical community's hopes, inspirations, and unanswered questions regarding research for an HIV cure.

Fernanda Fernandes Fonseca and Meg Doherty at an IAS 2019 press conference

World Health Organization Updates Guidance on Dolutegravir After Reassuring Data Regarding Safety in Early Pregnancy

New study results leave many experts feeling they went too far in their concerns over birth defect risks associated with the drug.

Doctors consultation

Having Fallen Out of Care, Most Gay and Bisexual Men With Detectable HIV Viral Loads Were Successfully Reconnected, Study Finds

The study enrolled more than a thousand people in four U.S. cities: Atlanta, Baltimore, Birmingham, and Boston.

Mexico City's Downtown At Twilight

IAS 2019: What to Expect in HIV Science

Six thousand HIV researchers and experts are expected to make their way to Mexico City for the 10th International AIDS Society Conference on HIV Science, which will feature more than 1,000 abstracts highlighting the latest findings in HIV treatment, prevention, and public health policy.

Depression Linked to Cognitive Dysfunction in HIV-Positive Women Img

Depression Linked to Cognitive Dysfunction in HIV-Positive Women

More research is needed to understand the connections between HIV, mental health, and the neurocircuitry that controls executive function.

TAF as Effective as TDF in Cisgender Women, With Fewer Side Effects Img

TAF as Effective as TDF in Cisgender Women, With Fewer Side Effects

A pooled analysis presented at CROI 2019 showed fewer kidney and bone density issues with tenofovir alafenamide in cisgender women than were found with the older formulation.

Viral Reservoir Can Explain Persistent Low Level Viremia With Good Adherence on ART Img

Viral Reservoir Can Explain Persistent Low Level Viremia With Good Adherence on ART

A CROI 2019 study suggests the dynamics of HIV proliferation in the viral reservoir might explain why viral load sometimes fails to become undetectable, especially when adherence is good.

Really Rapid Review: International AIDS Conference 2018, Amsterdam Img

Really Rapid Review: International AIDS Conference 2018, Amsterdam

Paul Sax, M.D., provides highlights of the important and interesting studies that caught his eye at AIDS 2018.

blood vials

Blood, Hair, or Urine? Weighing PrEP Adherence Options Beyond Self-Report

There are a number of measures determine adherence to PrEP, each with benefits and drawbacks. Currently, no one guideline or definitive standard is being used.